Shu et al. [27] proved for the first time that ANG could play a pivotal role in the development of bladder cancer through regulating AKT/mTOR (serine threonine kinase/mammalian target of rapamycin) signaling pathway. This evidence concerns the gene MTOR and urinary bladder carcinoma.